Home Vivus: Qsymia Sales Dip - Is A Lower Price Needed?
 

Keywords :   


Vivus: Qsymia Sales Dip - Is A Lower Price Needed?

2015-02-08 09:08:40| Biotech - Topix.net

Vivus investors have seen Qsymia scripts remain in a pretty tight channel for over 15 months. While the sales have remained fairly steady, the arrival of a new competitor could have shifted the market in such a way that Vivus will have little choice but to respond.

Tags: price sales needed lower

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
03.07Hurricane Beryl Graphics
03.07Hurricane Beryl Public Advisory Number 18A
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Eastern North Pacific Tropical Weather Outlook
03.07Atlantic Tropical Weather Outlook
03.07Benefits of benchmarking in the pork industry
03.07Hurricane Beryl Graphics
03.07Hurricane Beryl Forecast Discussion Number 18
More »